Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2023 | YoY |
|---|---|---|
| Revenue | 4.06M | 46.94% |
| Gross profit | 536K | 164.73% |
| Net profit | -14.15M | 43.29% |
| EBITDA | -9.64M | 24.41% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €23.95M |
Number of shares | 42.77M |
52-week high/low | €1.04 - €0.21 |
| Dividends | No |
Beta | 1.33 |
P/E ratio | -4.23 |
PEG ratio | -0.15 |
P/B ratio | 1.20 |
P/S ratio | 3.34 |
Company profile
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, and nutrition sectors in France and internationally. It offers DHA ORIGINS, a plant based DHA oil; PROTEALG, a vegetable protein; BLUE ORIGIN, a natural color substitutes for human health and nutrition; and Carbon sinks to capture CO2 in urban and industrial environments. The company was founded in 2009 and is headquartered in Libourne, France.
| Name | Fermentalg |
| CEO | Pierre Josselin |
| Headquarters | Libourne,
France |
| Website | |
| Sector | Health Care |
| Industry | Biotechnology |
| IPO | 04/16/2014 |
| Employees | 57 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | FALG.PA |
Frankfurt | 1F6.F |
London | 0QTJ.L |
Paris | ALGAE.PA |
München | 1F6.MU |
Düsseldorf | 1F6.DU |
